Accustem Sciences Inc. SEC filings ACUT
Accustem Sciences Inc. has 76 filings in SEC EDGAR's recent list, going back to Mar 12, 2021. Its latest annual report, Form 10-K, was filed on Apr 14, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 26, 2025 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Nov 26, 2025 | Nov 26, 2025 |
| 8-K/A |
Amended current report
Auditor change
|
Jan 2, 2025 | Jun 17, 2024 |
| 8-K |
Current report
Auditor change
|
Dec 30, 2024 | Jun 17, 2024 |
| 8-K |
Current report
Auditor change
|
Apr 10, 2024 | Apr 4, 2024 |
| 8-K |
Current report
Officer or director change
|
Jun 9, 2023 | Jun 5, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 7, 2023 | Jun 6, 2023 |
| 8-K |
Current report
Officer or director change
|
Nov 16, 2022 | Nov 14, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Oct 14, 2022 | Oct 14, 2022 |
| 8-K |
Current report
Officer or director change
|
Jun 21, 2022 | Jun 20, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change
|
Apr 5, 2022 | Mar 30, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 10, 2022 | Mar 4, 2022 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Other events
|
Dec 3, 2021 | Dec 1, 2021 |
Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ACUT (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1850767
- Former names
- AccuStem Sciences Ltd (until Jul 1, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.